CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383982704
- Phone
- 6096193990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 424B3 Offering Prospectus
- 8-K Event Material agreement · New debt or obligation · Delisting notice · Unregistered share sale · Shareholder rights changed · Other events
- 8-K Event Results of operations · Executive or director change
- 10-K Report Annual Report
- 8-K Event Unregistered share sale
- 4/A Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change · Shareholder vote results
- 10-Q Report Quarterly Report
Page 26 of 42 · 833 filings